189 related articles for article (PubMed ID: 8348065)
21. The immunophenotype of blast transformation of chronic myelogenous leukemia: a high frequency of mixed lineage phenotype in "lymphoid" blasts and A comparison of morphologic, immunophenotypic, and molecular findings.
Khalidi HS; Brynes RK; Medeiros LJ; Chang KL; Slovak ML; Snyder DS; Arber DA
Mod Pathol; 1998 Dec; 11(12):1211-21. PubMed ID: 9872654
[TBL] [Abstract][Full Text] [Related]
22. Lineage commitment in biphenotypic acute leukemia.
Buccheri V; Matutes E; Dyer MJ; Catovsky D
Leukemia; 1993 Jun; 7(6):919-27. PubMed ID: 8501986
[TBL] [Abstract][Full Text] [Related]
23. Philadelphia chromosome-positive acute myeloid leukemia: cytoimmunologic and cytogenetic features.
Cuneo A; Ferrant A; Michaux JL; Demuynck H; Boogaerts M; Louwagie A; Doyen C; Stul M; Cassiman JJ; Dal Cin P; Castoldi G; Van den Berghe H
Haematologica; 1996; 81(5):423-7. PubMed ID: 8952155
[TBL] [Abstract][Full Text] [Related]
24. [Immunophenotype characteristics and prognosis of acute leukemia patients with cross expressing lymphoid and myeloid lineage associated antigens].
Jiang NG; Chen XM; Zhu HL; Zhong L; Zeng TT; Jia YQ
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2010 Dec; 18(6):1405-9. PubMed ID: 21176339
[TBL] [Abstract][Full Text] [Related]
25. Clinical features and biological implications of acute mixed lineage (hybrid) leukemias.
Altman AJ
Am J Pediatr Hematol Oncol; 1990; 12(2):123-33. PubMed ID: 2198821
[TBL] [Abstract][Full Text] [Related]
26. Distinct cytogenetic and clinicopathologic features in acute myeloid leukemia after occupational exposure to pesticides and organic solvents.
Fagioli F; Cuneo A; Piva N; Carli MG; Previati R; Balboni M; Tomasi P; Cariani D; Scapoli G; Castoldi G
Cancer; 1992 Jul; 70(1):77-85. PubMed ID: 1606550
[TBL] [Abstract][Full Text] [Related]
27. Aberrant lymphoid antigen expression in acute myeloid leukemia in Saudi Arabia.
El-Sissy AH; El-Mashari MA; Bassuni WY; El-Swaayed AF
J Egypt Natl Canc Inst; 2006 Sep; 18(3):244-9. PubMed ID: 17671534
[TBL] [Abstract][Full Text] [Related]
28. Lymphoid lineage-associated features in acute myeloid leukaemia: phenotypic and genotypic correlations.
Paietta E; Van Ness B; Bennett J; Racevskis J; Gucalp R; Cassileth P; Wiernik PH
Br J Haematol; 1992 Oct; 82(2):324-31. PubMed ID: 1419814
[TBL] [Abstract][Full Text] [Related]
29. Dyshematopoiesis in de novo acute myeloid leukemia: cell biological features and prognostic significance.
Meckenstock G; Aul C; Hildebrandt B; Heyll A; Germing U; Wehmeier A; Giagounidis A; Suedhoff T; Burk M; Soehngen D; Schneider W
Leuk Lymphoma; 1998 May; 29(5-6):523-31. PubMed ID: 9643566
[TBL] [Abstract][Full Text] [Related]
30. Analysis of treatment failure in patients with minimally differentiated acute myeloid leukemia (AML-M0).
Stasi R; Del Poeta G; Venditti A; Masi M; Stipa E; Dentamaro T; Cox C; Dallapiccola B; Papa G
Blood; 1994 Mar; 83(6):1619-25. PubMed ID: 8123853
[TBL] [Abstract][Full Text] [Related]
31. Association of GP40/CD7+ acute myeloblastic leukemia and chromosome 5 aberrations.
Lutz D; Kasparu H; Nowotny H; Weber E; Krieger O; Köller U; Tüchler H; Knapp W
Haematol Blood Transfus; 1990; 33():141-4. PubMed ID: 1691128
[No Abstract] [Full Text] [Related]
32. Surface marker analysis and karyotype distinguish acute biphenotypic leukemia from acute myelogenous leukemia expressing terminal deoxynucleotidyl transferase.
Moscinski LC; Nowell PC; Hoxie JA; Berger MS; Prystowsky MB
Cancer; 1991 Nov; 68(10):2161-8. PubMed ID: 1913454
[TBL] [Abstract][Full Text] [Related]
33. Clinical significance of co-expression of aberrant antigens in acute leukemia: a retrospective cohort study in Makah Al Mukaramah, Saudi Arabia.
Abdulateef NA; Ismail MM; Aljedani H
Asian Pac J Cancer Prev; 2014; 15(1):221-7. PubMed ID: 24528030
[TBL] [Abstract][Full Text] [Related]
34. Cytogenetic profile of minimally differentiated (FAB M0) acute myeloid leukemia: correlation with clinicobiologic findings.
Cuneo A; Ferrant A; Michaux JL; Boogaerts M; Demuynck H; Van Orshoven A; Criel A; Stul M; Dal Cin P; Hernandez J
Blood; 1995 Jun; 85(12):3688-94. PubMed ID: 7780152
[TBL] [Abstract][Full Text] [Related]
35. Prognostic impact of specific chromosomal aberrations in a large group of pediatric patients with acute myeloid leukemia treated uniformly according to trial AML-BFM 98.
von Neuhoff C; Reinhardt D; Sander A; Zimmermann M; Bradtke J; Betts DR; Zemanova Z; Stary J; Bourquin JP; Haas OA; Dworzak MN; Creutzig U
J Clin Oncol; 2010 Jun; 28(16):2682-9. PubMed ID: 20439630
[TBL] [Abstract][Full Text] [Related]
36. Relapse and cytogenetic evolution in myeloid neoplasms.
Ertz-Archambault N; Kelemen K
Panminerva Med; 2017 Dec; 59(4):308-319. PubMed ID: 29144072
[TBL] [Abstract][Full Text] [Related]
37. [Classification of AML by morphologic, immunologic and cytogenetic criteria. Review with reference to subtypes in the AML-BFM-87 study].
Creutzig U; Ritter J; Ludwig WD; Harbott J; Löffler H; Schellong G
Klin Padiatr; 1993; 205(4):272-80. PubMed ID: 8377447
[TBL] [Abstract][Full Text] [Related]
38. Lack of correlation between immunoglobulin and T cell receptor gene rearrangements and TdT expression in acute myeloid leukaemia.
Davey G; Bradstock KF; Kefford RF; Wishart Y; Kabral A; Grimsley P; Hughes WG
Leuk Res; 1990; 14(1):77-83. PubMed ID: 1689438
[TBL] [Abstract][Full Text] [Related]
39. Characteristics of t(8;21) acute myeloid leukemia (AML) with additional chromosomal abnormality: concomitant trisomy 4 may constitute a distinctive subtype of t(8;21) AML.
Nishii K; Usui E; Katayama N; Lorenzo F; Nakase K; Kobayashi T; Miwa H; Mizutani M; Tanaka I; Nasu K; Dohy H; Kyo T; Taniwaki M; Ueda T; Kita K; Shiku H
Leukemia; 2003 Apr; 17(4):731-7. PubMed ID: 12682630
[TBL] [Abstract][Full Text] [Related]
40. Biphasic acute myeloid leukemia with near-tetraploidy and immunophenotypic transformation.
Imkie M; Davis MK; Persons DL; Cunningham MT
Arch Pathol Lab Med; 2004 Apr; 128(4):448-51. PubMed ID: 15043460
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
